Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-054432

Options or other derivatives

  • Director acquired 10,904 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Weis Holger Director 2025-04-13 Grant or award · Employee Stock Option (right to buy) +10,904 10,904 D
Loading xslF345X05/ownership.xml…